Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.47 - $0.88 $1,089 - $2,040
-2,319 Reduced 15.78%
12,373 $10,000
Q3 2023

Nov 14, 2023

BUY
$0.58 - $1.41 $2,165 - $5,264
3,734 Added 34.08%
14,692 $8,000
Q2 2023

Aug 14, 2023

BUY
$0.56 - $1.2 $6,136 - $13,149
10,958 New
10,958 $11,000
Q2 2022

Aug 15, 2022

BUY
$0.75 - $1.33 $7,686 - $13,631
10,249 New
10,249 $8,000

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $26.8M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.